NCT06302023已完成2 期
Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor
适应症
干预措施
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Number of Participants with preterm birth
研究概览
简要总结
The goal of this clinical trial is to learn about the effects of Docosahexaenoic acid (DHA) in reducing the incidence of premature birth in threatened preterm labor
The main questions it aims to answer are:
- Can DHA supplementation reduce the incidence of premature birth in threatened preterm labor?
- How does DHA supplementation affect pregnancy outcomes? Participants were organized into two groups
- Group 1 (Intervention) Participants will be asked to take a DHA 1000mg per day
- Group 2 (control) Participant will not need to take a DHA
详细描述
Threatened preterm labor is defined as regular uterine contractions occurring before 37 completed weeks of gestation, without any cervical dilation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Singleton pregnancy
- •Between 24 wk to 34 wk of gestational age
- •Pregnant women diagnosed threatened preterm labor (with no cervical change)
排除标准
- •Fetal anomalies
- •Multiple pregnancy
- •Premature rupture of membrane
- •Placental disorders: placenta previa, placental abruption
- •Fetal growth restriction
- •Pregnancy complication: gestational diabetes mellitus, Chronic hypertension
- •Allergic reaction to DHA
研究组 & 干预措施
DHA supplement
Experimental
DHA supplement 1000mg per day
干预措施: Docosahexaenoic acid (DHA) 1000 mg (Dietary Supplement)
no DHA supplement
No Intervention
no DHA supplement
结局指标
主要结局
Number of Participants with preterm birth
时间窗: at delivery time
Delivery at less than 37 weeks of gestational age
次要结局
- Rate of low birth weight neonate(at delivery time)
- Rate of Neonatal Intensive care unit admission(at delivery time)
研究者
Wiphawi Phattharachindanuwong
Fellow, Maternal and Fetal medicine department, Obstetrics and gynecology department
Khon Kaen University
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis PigmentosaRetinitis PigmentosaNCT00004827Retina Foundation of the Southwest46
Unknown
2 期
High Dose Omega 3 in People at Risk for DementiaInflammationMild Cognitive ImpairmentCognitive DeclineSCDCognitive DysfunctionPathologic ProcessesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersDementiaCognition DisordersMental DisorderNCT03926351University Hospital, Akershus40
已完成
不适用
Memory Improvement With Docosahexaenoic Acid Study (MIDAS)Age-Related Cognitive DeclineAge-Related Memory DisordersNCT00278135DSM Nutritional Products, Inc.485
已完成
3 期
Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin ARetinitis PigmentosaNCT00000116Carol Weigel DiFranco221
Unknown
4 期
Effect of Docosahexaenoic Acid Supplementation on Microbiome in Obese ChiLdrEn.Childhood ObesityNCT04151758University of Milan30